Anti-HPTR/ HPR/ A-259H10.2 functional antibody

Anti-HPTR/ HPR/ A-259H10.2 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to HPR/HPR products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0969-Ab-1/ GM-Tg-hg-SE0969-Ab-2Anti-Human HPR monoclonal antibodyHuman
GM-Tg-rg-SE0969-Ab-1/ GM-Tg-rg-SE0969-Ab-2Anti-Rat HPR monoclonal antibodyRat
GM-Tg-mg-SE0969-Ab-1/ GM-Tg-mg-SE0969-Ab-2Anti-Mouse HPR monoclonal antibodyMouse
GM-Tg-cynog-SE0969-Ab-1/ GM-Tg-cynog-SE0969-Ab-2Anti-Cynomolgus/ Rhesus macaque HPR monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0969-Ab-1/ GM-Tg-felg-SE0969-Ab-2Anti-Feline HPR monoclonal antibodyFeline
GM-Tg-cang-SE0969-Ab-1/ GM-Tg-cang-SE0969-Ab-2Anti-Canine HPR monoclonal antibodyCanine
GM-Tg-bovg-SE0969-Ab-1/ GM-Tg-bovg-SE0969-Ab-2Anti-Bovine HPR monoclonal antibodyBovine
GM-Tg-equg-SE0969-Ab-1/ GM-Tg-equg-SE0969-Ab-2Anti-Equine HPR monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0969-Ab-1/ GM-Tg-hg-SE0969-Ab-2; GM-Tg-rg-SE0969-Ab-1/ GM-Tg-rg-SE0969-Ab-2;
GM-Tg-mg-SE0969-Ab-1/ GM-Tg-mg-SE0969-Ab-2; GM-Tg-cynog-SE0969-Ab-1/ GM-Tg-cynog-SE0969-Ab-2;
GM-Tg-felg-SE0969-Ab-1/ GM-Tg-felg-SE0969-Ab-2; GM-Tg-cang-SE0969-Ab-1/ GM-Tg-cang-SE0969-Ab-2;
GM-Tg-bovg-SE0969-Ab-1/ GM-Tg-bovg-SE0969-Ab-2; GM-Tg-equg-SE0969-Ab-1/ GM-Tg-equg-SE0969-Ab-2
Products NameAnti-HPR monoclonal antibody
Formatmab
Target NameHPR
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-HPR benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0969-Ag-1Recombinant multi-species HPTR/ HPR/ A-259H10.2 protein


    Target information

    Target IDGM-SE0969
    Target NameHPR
    Gene ID3250
    Gene Symbol and SynonymsA-259H10.2,HP,HPR
    Uniprot AccessionP00739
    Uniprot Entry NameHPTR_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000261701
    Target ClassificationN/A

    The target: HPR, gene name: HPR, also named as A-259H10.2, HP. This gene encodes a haptoglobin-related protein that binds hemoglobin as efficiently as haptoglobin. Unlike haptoglobin, plasma concentration of this protein is unaffected in patients with sickle cell anemia and extensive intravascular hemolysis, suggesting a difference in binding between haptoglobin-hemoglobin and haptoglobin-related protein-hemoglobin complexes to CD163, the hemoglobin scavenger receptor. This protein may also be a clinically important predictor of recurrence of breast cancer. [provided by RefSeq, Oct 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.